MAM
Monaco Asset Management Portfolio holdings
AUM
$264M
This Quarter Return
+10.51%
1 Year Return
+6.34%
3 Year Return
+31.77%
5 Year Return
–
10 Year Return
–
AUM
$260M
AUM Growth
+$260M
(+30%)
Cap. Flow
+$35.2M
Cap. Flow
% of AUM
13.53%
Top 10 Holdings %
Top 10 Hldgs %
51.23%
Holding
93
New
22
Increased
27
Reduced
18
Closed
11
Top Buys
| 1 |
Agnico Eagle Mines
AEM
|
$13.5M |
| 2 |
Newmont
NEM
|
$8.65M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
$8.23M |
| 4 |
Pfizer
PFE
|
$5.76M |
| 5 |
Baidu
BIDU
|
$4.61M |
Top Sells
| 1 |
VanEck Gold Miners ETF
GDX
|
$20.2M |
| 2 |
AngloGold Ashanti
AU
|
$7.29M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.17M |
| 4 |
StoneCo
STNE
|
$6.24M |
| 5 |
UBS Group
UBS
|
$3.06M |
Sector Composition
| 1 | Materials | 36.04% |
| 2 | Healthcare | 29.99% |
| 3 | Technology | 9.58% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Financials | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
ProQR Therapeutics
PRQR
$237M
| $749K | 0.22% |
378,476
+959
| +0.3% | +$1.9K |
|
52
Esperion Therapeutics
ESPR
$448M
| $728K | 0.21% |
243,642
-928,137
| -79% | -$2.78M |
|
53
NovoCure
NVCR
$1.38B
| $677K | 0.2% |
+45,336
| New | +$677K |
|
54
Perrigo
PRGO
$3.27B
| $644K | 0.19% |
+20,000
| New | +$644K |
|
55
Taysha Gene Therapies
TSHA
$797M
| $522K | 0.15% |
+295,000
| New | +$522K |
|
56
Compass Minerals
CMP
$794M
| $506K | 0.15% |
+20,000
| New | +$506K |
|
57
MP Materials
MP
$12.6B
| $496K | 0.15% |
+25,000
| New | +$496K |
|
58
Ericsson
ERIC
$26.2B
| $473K | 0.14% |
75,000
-75,000
| -50% | -$473K |
|
59
VEON
VEON
$4.05B
| $469K | 0.14% |
23,800
+13,800
| +138% | +$272K |
|
60
Vanda Pharmaceuticals
VNDA
$279M
| $359K | 0.11% |
85,000
-50,000
| -37% | -$211K |
|
61
Novavax
NVAX
$1.21B
| $322K | 0.09% |
67,149
+37,149
| +124% | +$178K |
|
62
First Majestic Silver
AG
$4.47B
| $308K | 0.09% |
50,000
-50,000
| -50% | -$308K |
|
63
Galapagos
GLPG
$2.07B
| $274K | 0.08% |
6,744
-1,714
| -20% | -$69.7K |
|
64
Gossamer Bio
GOSS
$562M
| $256K | 0.08% |
+280,000
| New | +$256K |
|
|
BLUE
65
DELISTED
bluebird bio
BLUE
| $207K | 0.06% |
+150,000
| New | +$207K |
|
66
Jasper Therapeutics
JSPR
$45.5M
| $197K | 0.06% |
+249,563
| New | +$197K |
|
|
BCOV
67
DELISTED
Brightcove, Inc.
BCOV
| $142K | 0.04% |
+55,000
| New | +$142K |
|
|
EAR
68
DELISTED
Eargo, Inc. Common Stock
EAR
| $130K | 0.04% |
+50,000
| New | +$130K |
|
69
BuzzFeed
BZFD
$72.6M
| $125K | 0.04% |
+500,000
| New | +$125K |
|
70
Adverum Biotechnologies
ADVM
$64.6M
| $59.6K | 0.02% |
79,234
+20,000
| +34% | +$15.1K |
|
71
Apple
AAPL
$3.45T
| – | – |
0
| – | – |
|
72
Chewy
CHWY
$16.9B
| – | – |
-47,500
| Closed | -$867K |
|
73
Canadian Imperial Bank of Commerce
CM
$71.8B
| – | – |
0
| – | – |
|
74
Costco
COST
$418B
| – | – |
0
| – | – |
|
75
Freedom Holding
FRHC
$10.5B
| – | – |
0
| – | – |
|